Albert Bourla is the Chairman and CEO of Pfizer. Please support this podcast by checking out our sponsors: – Notion: https://notion.com/startups to get up to $1000 off team plan – Calm: https://calm.com/lex to get 40% off – Hunter Douglas: https://www.hunterdouglas.com/lex to get a free design guide – LMNT: https://drinkLMNT.com/lex to get free sample pack – Grammarly: https://grammarly.com/lex to get 20% off premium EPISODE LINKS: Albert’s Twitter: https://twitter.com/AlbertBourla Pfizer’s Website: https://www.pfizer.com/ PODCAST INFO: Podcast website: https://lexfridman.com/podcast Apple Podcasts: https://apple.co/2lwqZIr Spotify: https://spoti.fi/2nEwCF8 RSS: https://lexfridman.com/feed/podcast/ YouTube Full Episodes: https://youtube.com/lexfridman YouTube Clips: https://youtube.com/lexclips SUPPORT & CONNECT: – Check out the sponsors above, it’s the best way to support this podcast – Support on Patreon: https://www.patreon.com/lexfridman – Twitter: https://twitter.com/lexfridman – Instagram: https://www.instagram.com/lexfridman – LinkedIn: https://www.linkedin.com/in/lexfridman – Facebook: https://www.facebook.com/lexfridman – Medium: https://medium.com/@lexfridman OUTLINE: Here’s the timestamps for the episode. On some podcast players you should be able to click the timestamp to jump to that time. (00:00) – Introduction (10:08) – Clinical trials (26:12) – Trust (45:59) – Safety (56:16) – Booster shots (59:09) – Mandates (1:05:39) – Antivirals (1:10:38) – Hope for future

Scott Bultright, CEO of Chipotle, shares insights on the company's impressive financial performance and future growth strategies. Albert Bourla, Chairman and CEO of Pfizer, discusses the pharma sector's rebounds and innovative treatments, including their promising cancer research. Ian Kryze, CEO of Mattel, highlights the company's strong earnings and exciting plans for expansion, like new entertainment ventures. Together, they present a dynamic view of industry trends, trade impacts, and strategic innovations shaping their respective markets.

Albert Bourla, CEO of Pfizer, discusses the company's focus on innovative cancer treatments and the role of AI in drug development. Ray Dalio shares insights on rising global debt, urging smart management for economic stability. Matthew Schrag, a neurologist at Vanderbilt, raises red flags about research integrity in Alzheimer's treatments, stressing the urgent need for accountability in scientific studies. Together, they explore the intersection of healthcare innovation and economic challenges, emphasizing the importance of prioritizing effective therapies.